Search company, investor...

Ensemble Therapeutics

ensembletx.com

Founded Year

2002

Stage

Dead | Dead

Total Raised

$15M

About Ensemble Therapeutics

Ensemble Therapeutics is an early stage company focused on translating fundamental innovation in chemical discovery into products that address needs life science, materials, electronics, and chemical markets.

Headquarters Location

99 Erie Street

Cambridge, Massachusetts, 02139,

United States

617-492-6977

Missing: Ensemble Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Ensemble Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Ensemble Therapeutics Patents

Ensemble Therapeutics has filed 6 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/7/2013

3/28/2017

Experimental cancer drugs, Programmed cell death, Protein kinase inhibitors, Fluoroarenes, Cancer treatments

Grant

Application Date

11/7/2013

Grant Date

3/28/2017

Title

Related Topics

Experimental cancer drugs, Programmed cell death, Protein kinase inhibitors, Fluoroarenes, Cancer treatments

Status

Grant

Latest Ensemble Therapeutics News

Ensemble Therapeutics Corp Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27092018 Prices from USD $250

Oct 28, 2018

08:13 EDT 28 Oct 2018 | BioPortfolio Reports Summary Ensemble Therapeutics Corp Ensemble, formerly Ensemble Discovery Corp is a developer of small molecule therapies for the treatment of cancer and other serious diseases. The company develops its products using its proprietary drug discovery platform. Its products under development are used for the treatment of various therapeutic areas including prostate , colorectal, pancreatic, cervical, gastric, ovarian, and lung cancers; parkinson's, hepatitis B and cardiovascular, among others. The company has partnership with various pharmaceutical companies to develop its small molecule therapies. Ensemble is headquartered in Cambridge, Massachusetts, the US. Ensemble Therapeutics Corp Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Ensemble Therapeutics Frequently Asked Questions (FAQ)

  • When was Ensemble Therapeutics founded?

    Ensemble Therapeutics was founded in 2002.

  • Where is Ensemble Therapeutics's headquarters?

    Ensemble Therapeutics's headquarters is located at 99 Erie Street, Cambridge.

  • What is Ensemble Therapeutics's latest funding round?

    Ensemble Therapeutics's latest funding round is Dead.

  • How much did Ensemble Therapeutics raise?

    Ensemble Therapeutics raised a total of $15M.

  • Who are the investors of Ensemble Therapeutics?

    Investors of Ensemble Therapeutics include 180 Degree Capital, Flagship Pioneering, Boston University Technology Development, Oxford Bioscience Partners, ARCH Venture Partners and 5 more.

  • Who are Ensemble Therapeutics's competitors?

    Competitors of Ensemble Therapeutics include PharmOptima, IntelliCyt, Aquapharm, Bioscience Vaccines, BioTrove and 11 more.

Compare Ensemble Therapeutics to Competitors

S
Sword Diagnostics

Sword Diagnostics is a life sciences company created in response to the needs of the research, pharmaceutical, and clinical communities. Although researchers are discovering thousands of biomarkers associated with both healthy and diseased-related biological processes, today's life science tools are unable to effectively measure, quantify, and determine the ultimate value of these biological markers. Sword Diagnostics' technology is directly aimed at making it easier to understand these newly emerging biomarkers, as well as extending the utility of existing diagnostics assays. Sword's mission is to provide the next-generation detection technology to life scientists, enabling them to continue advances in medical research, drug discovery and the provision of health care products and services.

Fluxion Biosciences Logo
Fluxion Biosciences

Fluxion Biosciences is a developer of precision solutions for life science research and diagnostics. Fluxion's liquid biopsy solutions are changing how cancer is detected and treated. Fluxion's pioneering liquid biopsy technologies include the IsoFlux CTC Liquid Biopsy System, ERASE-Seq ultra-sensitive variant caller, and the Spotlight 59 NGS Oncology Panel for cancer mutation detection from cell-free circulating tumor DNA. Fluxion's technologies are used globally by cancer centers developing new tests for early cancer detection and patient monitoring.

I
InterMed Discovery

InterMed Discovery is a Natural Product lead-discovery company, driving innovation through the generation of product candidates for the life science, food and cosmetics industries. Using a powerful validated Natural Product discovery engines, InterMed Discovery generates product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation.

A
Anthill Technologies

Anthill Technologies, Inc. is pioneering the development and commercialization of a unique proprietary applied chemistry operating system (ACOS�) and a novel high-speed chemical discovery engine based on this operating system to dramatically reduce the time, cost and risk factors associated with discovering and developing chemical compositions, pathways, processes and products for applications in both life science and non-life science markets.

G
Genomic Solutions

The scientists at Genomic Solutions have a wealth of genomic, protein analysis and nano-liter dispensing application-based expertise that they would like to share with users. First select their area of research, followed by interest and then application, and finally, to the company's instrumentation which can help facilitate their research. Whether users are involved in the life science or biotechnology research community, the company's products will enable users to perform complex, high volume experiments at a lower cost and in less time than traditional techniques. You achieve rapid and less expensive drug discovery.

M
MerLion Pharmaceuticals

MerLion Pharmaceuticals focuses on the discovery and development of drug candidates from natural sources. MerLion collaborates with leading pharmaceutical companies, biotechs and research institutes to identify and develop drug leads in a wide range of therapeutic areas.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.